K Number
K171081
Date Cleared
2017-05-09

(28 days)

Product Code
Regulation Number
870.1340
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The RXI Guider ™ Catheter Introducer is indicated for introducing various cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.

Device Description

The Guider Catheter Introducer set contains a fixed-curve introducer, integrated vessel dilator/transseptal needle (component branded as Lancer™), guidewire, and ECG adapter cable. The set is designed to facilitate vascular access to the heart and then provide catheter positioning within the cardiac anatomy. The Guider Catheter Introducer is an elongated shaft with central lumen capable of accepting the Lancer dilator/needle as well as various catheters. The Guider handle is also fitted with a hemostasis valve to minimize blood loss during catheter introduction, and/or exchange, as well as a sideport with 3way stopcock to allow blood aspiration, fluid infusion, and pressuremonitoring. The introducer shaft features distal side holes to facilitate aspiration and prevent cavitation plus an embedded platinum radiopaque tip marker to facilitate fluoroscopic visualization. The Lancer integrated dilator/needle combines a dilator and transseptal needle into a single component. The needle is used to puncture the interatrial septum to gain access to the left atrium. The Lancer consists of an elongated shaft with a tapered tip and central lumen to track over a guidewire in a similar fashion to conventional dilators. The lumen of the Lancer is fitted with a hollow stainless steel transseptal needle and both the shaft and needle are connected to the same proximal handle. The needle lumen will accept guidewire sizes up to 0.032 inches in diameter. Inside the Lancer handle, the needle is affixed to a spring-tensioned actuator that prevents needle extension until the operator purposely advances the needle via a slider button located on the outer surface of the handle. The proximal handle is fitted with a Luer connector to gain access to the central lumen of the needle. The handle is also fitted with an electrical connector to monitor an ECG from the needle while in the heart, utilizing the ECC adapter cable. The guidewire included in the set is manufactured by Lake Region Medical (K935170) and is supplied in a polypropylene retainer coil with a J-straightener and Luer fitting. The ECG adapter cable included is manufactured by Bioconnect (RF Industries, Inc.), is one (1) meter long, and has male/female DIN 0.080 inch touch- proof connectors on the ends.

AI/ML Overview

The provided text describes the "Guider Catheter Introducer" and its testing for substantial equivalence to a predicate device. However, it does not describe an AI/ML powered medical device. Therefore, many of the requested categories related to AI performance, ground truth, and expert evaluation are not applicable or cannot be extracted from this document.

The document primarily focuses on non-clinical testing (biocompatibility, sterilization, packaging, shelf life, and performance testing) and an animal study to demonstrate the device meets safety and performance requirements and is substantially equivalent to a predicate.

Here's the information that can be extracted, with notes where the requested categories are not applicable.

Acceptance Criteria and Device Performance (Summary from various sections)

Test TypeAcceptance Criteria (Implied/Stated)Reported Device Performance
BiocompatibilityNon-hemolytic, non-reactive (complement), pass (platelet/leukocyte), non-activator (PTT), pass (PT), non-cytotoxic, non-sensitizer, non-irritant, non-pyrogenic, non-toxic (systemic), non-thrombogenicAll tests passed, explicitly stating "Non-Hemolytic", "Non-Reactive", "Pass", "Non-Activator", "Pass", "Non-Cytotoxic", "Non-Sensitizer", "Non-Irritant", "Non-Pyrogenic", "Pass, Non-Toxic", "Pass, Non-Thrombogenic"
SterilizationAchieve 10^-6 sterility assurance level (SAL)Protocol established, validation pending (at time of submission)
PackagingMaintain sterile barrier, withstand distribution simulationAll distribution and packaging testing passed
Shelf LifeMaintain performance and sterile barrier for 12 monthsPassed all baseline and accelerated aging testing (simulating 12 months)
Performance (Mechanical/Functional)All protocol requirements/specifications met (e.g., pushability, trackability, leak, coating integrity, kink resistance, tensile strengths, electrical safety, radiopacity, needle actuation)All protocol requirements/specifications were met
Animal StudyPerform substantially equivalent to predicate devicePerformed substantially equivalent to the predicate device

1. A table of acceptance criteria and the reported device performance:

As provided above. The document generally states "Pass" or "All protocol requirements/specifications were met" rather than specific numerical acceptance criteria for many tests, except for biocompatibility where "Non-Hemolytic", "Non-Reactive", etc., serve as the criteria.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

  • Test Set Sample Size: Not explicitly stated numerically for most non-clinical tests. For the animal study, it mentions "2 canines" for in vivo thrombogenicity and "A single animal study" for the overall device performance comparison, but doesn't quantify the number of devices or trials within that study.
  • Data Provenance:
    • Biocompatibility and animal study: American Preclinical Services, Inc., Minneapolis, MN, USA.
    • Sterilization: Steris Isomedix, Minneapolis, MN, USA.
    • Environmental Conditioning, Distribution Simulation, Accelerated Aging, Peel Strength, Bubble Leak Testing: Distribution Dynamic Labs, Inc. (DDL) in Eden Prairie, MN, USA.
    • Particulate testing: Nelson Labs, Salt Lake City, UT, USA.
    • Electrical testing: Medical Equipment Compliance Associates, LLC. (MECA), Franklin, WI, USA.
    • All other testing: Internally at CRI-Devices in Maple Grove, MN, USA.
    • The studies are prospective, conducted specifically for this 510(k) submission.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

  • Not applicable for this type of device. This device is a catheter introducer, which is a physical medical instrument, not an AI/ML software device or diagnostic tool that requires expert-established ground truth on patient data. The "ground truth" here is the performance of the device against engineering specifications and regulatory standards, assessed by testing laboratories and the FDA.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

  • Not applicable. This refers to methods for resolving discrepancies in expert opinions for ground truth establishment in AI/ML studies. This document concerns physical device testing against predefined specifications.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

  • Not applicable. This is an AI/ML-specific study type. The document describes an animal study comparing the device to a predicate device, not human reader performance with AI. The animal study showed the device "performed for the selected parameters substantially equivalent to the commercially available St. Jude Medical Swartz™ Braided Transseptal Guiding Introducer (K052644)."

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

  • Not applicable. This relates to AI/ML algorithm performance. The device is a physical medical instrument.

7. The type of ground truth used (expert concensus, pathology, outcomes data, etc):

  • Not applicable in the AI/ML context. For physical device testing, the "ground truth" is established through adherence to recognized national and international standards (e.g., ISO, ASTM, AAMI) and internal performance specifications. For the animal study, the ground truth was the performance of the legally marketed predicate device under specific physiological parameters.

8. The sample size for the training set:

  • Not applicable. There is no AI/ML component, thus no training set.

9. How the ground truth for the training set was established:

  • Not applicable. No training set exists.

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines representing hair or clothing.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

May 09, 2017

Rhythm Xience, Inc. c/o Mark Job Regulatory Technology Services LLC 1394 25th Street NW Buffalo, MN 55313

Re: K171081

Trade/Device Name: Guider Catheter Introducer Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter Introducer Regulatory Class: Class II Product Code: DYB Dated: April 7, 2017 Received: April 11, 2017

Dear Mr. Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{1}------------------------------------------------

forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely,

M.A. Hilleman

for

Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known)

K171081

Device Name GUIDER™ CATHETER INTRODUCER

Indications for Use (Describe)

The RXI Guider ™ Catheter Introducer is indicated for introducing various cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.

Type of Use (Select one or both, as applicable)
-------------------------------------------------

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW *

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

5.0 510(k) SUMMARY AS REQUIRED BY 21 CFR 807.92

510(k) Number: K or TBD [X]

Date Prepared: March 22, 2017

Table 5.1 SUBMITTER INFORMATION

Submitter:Rhythm Xience Inc.
Street Address:10025 Valley View RoadSuite 130Eden Prairie, MN 55344
Contact Person:Jim Hassett
Phone:952-479-7903
Email:jimhassett@rhythm-xience.com

Establishment registration: awaiting 510(k) clearance prior to initial registration/listing

Table 5.2 DEVICE INFORMATION

Trade NameGuider™ Catheter Introducer
Common NameCatheter Introducer
Classification NameIntroducer, Catheter
Regulation /Product Code21 CFR 870.1340
Product CodeDYB
Regulatory Classification:Class II
Device Panel:Cardiovascular

The RXI Guider Catheter Introducer is substantially equivalent to the previously-cleared, St. Jude Medical (SJM) Swartz™ Braided Transseptal Guiding Introducer, K052644.

Table 5.3 PREDICATE DEVICE

Predicate DeviceManufacturerFDA 510(k)
Swartz™ Braided Transseptal GuidingIntroducerSt. Jude Medical, Inc.K052644

5.1 Device Description

The Guider Catheter Introducer set contains a fixed-curve introducer, integrated vessel dilator/transseptal needle (component branded as Lancer™), guidewire, and ECG adapter cable. The set is designed to facilitate vascular access to the heart and then provide catheter positioning within the cardiac anatomy (see Figure 5.1).

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows a "Guider™ Introducer Kit" laid out on a white surface against a dark background. The kit includes several components, such as a Guider Introducer, a Lancer dilator/needle, an ECG adapter, and a guidewire. The components are neatly arranged and labeled, providing a clear view of the kit's contents. The kit appears to be a medical device used for introducing catheters or other instruments into the body.

Figure 5.1 Guider Introducer Set

The Guider Catheter Introducer is an elongated shaft with central lumen capable of accepting the Lancer dilator/needle as well as various catheters. The Guider handle is also fitted with a hemostasis valve to minimize blood loss during catheter introduction, and/or exchange, as well as a sideport with 3way stopcock to allow blood aspiration, fluid infusion, and pressuremonitoring. The introducer shaft features distal side holes to facilitate aspiration and prevent cavitation plus an embedded platinum radiopaque tip marker to facilitate fluoroscopic visualization (see Figure 5.2 and Figure 5.3).

Image /page/4/Figure/3 description: This image shows a medical instrument with a fixed-curve tip. The instrument also has a sideport with a 3-way stopcock. The proximal handle has a hemostasis valve.

Figure 5.2 Guider Catheter Introducer

{5}------------------------------------------------

Image /page/5/Figure/0 description: The image shows a medical instrument with a blue handle and a long, thin, gray tube. The effective lengths of the instrument are 50 cm and 65 cm. The fixed curve angles are 45 degrees and 90 degrees. The inner diameter (ID) at the tip is .114" and .110", while the outer diameter (OD) at the tip is .158" and .140".

Figure 5.3 Guider Dimensional Drawing

The set includes the following accessories (see Figure 5.4):

  • Lancer Integrated Dilator/Needle
  • J-Tip Guidewire
  • ECG Adapter

Image /page/5/Picture/6 description: The image shows medical equipment including a Lancer dilator/needle, a guidewire, and an ECG adapter. The Lancer dilator/needle is blue and has a long, thin needle. The guidewire is a thin, flexible wire that is used to guide the catheter through the blood vessel. The ECG adapter is red and has two clips that attach to the patient's skin. The equipment is laid out on a white surface.

Figure 5.4 Guider Accessories

{6}------------------------------------------------

The Lancer integrated dilator/needle combines a dilator and transseptal needle into a single component (see Figures 5.5 - 5.7). The needle is used to puncture the interatrial septum to gain access to the left atrium similar to the St. Jude Medical BRK™ Transseptal Needle (K072278). The Lancer consists of an elongated shaft with a tapered tip and central lumen to track over a guidewire in a similar fashion to conventional dilators. The lumen of the Lancer is fitted with a hollow stainless steel transseptal needle and both the shaft and needle are connected to the same proximal handle. The needle lumen will accept guidewire sizes up to 0.032 inches in diameter. Inside the Lancer handle, the needle is affixed to a spring-tensioned actuator that prevents needle extension until the operator purposely advances the needle via a slider button located on the outer surface of the handle. The proximal handle is fitted with a Luer connector to gain access to the central lumen of the needle. The handle is also fitted with an electrical connector to monitor an ECG from the needle while in the heart, utilizing the ECC adapter cable. This is done in a similar manner as pericardiocentesis kits whereby electrocardiograms are monitored from the needle during use (reference Figure 5.8, Boston Scientific Peri Vac Pericardiocentesis Kit, K032050).

Figure 5.5 Lancer integrated dilator/needle. Panel A is a profile technical drawing depicting the internal components of the handle. Panel B illustrates the handle features.

{7}------------------------------------------------

Image /page/7/Figure/0 description: The image shows a medical device, specifically a needle inside the lumen of a dilator shaft. The device has a long, thin, blue shaft with a handle on one end. A magnified view shows the needle inside the dilator shaft, with markings along the shaft. The image provides a detailed view of the device's construction.

Figure 5.6 Lancer with inset depicting internal needle in baseline retracted position

Image /page/7/Figure/2 description: The image shows a diagram of a medical instrument. The instrument has a blue handle that is 9 cm long. The instrument has a long, thin tube with a fixed curve angle of 70 degrees at the end, and the needle at the end has an ID of .035" and an OD of .042".

Figure 5.7 Lancer Dimensional Drawing

{8}------------------------------------------------

Image /page/8/Picture/0 description: The image shows a medical kit in a white tray. The kit contains various medical supplies, including syringes, a guidewire, and an ECG adapter. The ECG adapter is labeled with an arrow pointing to it. The kit appears to be for a medical procedure, possibly involving cardiac monitoring.

Figure 5.8 Boston Scientific PeriVac Pericardiocentesis Kit

The distal end of the Lancer handle and the proximal end of the Guider handle are designed with male/female surfaces to mate the components together in a snap-fit closure (see Figure 5.9).

Image /page/8/Figure/3 description: The image shows a Lancer connected to a Guider. The Lancer and Guider are connected via a male/female interface. The Lancer is on the left side of the image, and the Guider is on the right side of the image.

Figure 5.9 Guider to Lancer mating feature

{9}------------------------------------------------

The guidewire included in the set is manufactured by Lake Region Medical (K935170) and is supplied in a polypropylene retainer coil with a J-straightener and Luer fitting. The Luer fitting is compliant to ISO 594-1 and ISO 594-2. The ECG adapter cable included is manufactured by Bioconnect (RF Industries, Inc.), is one (1) meter long, and has male/female DIN 0.080 inch touch- proof connectors on the ends.

The patient-contacting materials used in the Guider Catheter Introducer set are listed in Table 5.4. A detailed listing of all materials used in the set is provided in the submission.

ComponentMaterials
Guider
ShaftPebax (6333, 3533) with Barium Sulfate and gray colorantPolytetrafluoroethylene (PTFE)Polyvinyl chloride (PVC)Ethyl CyanoacrylatePolycarbonate, High Density Polyethylene (HDPE)Acrylic UV CurablePolypropylene, WhiteSiloxane Lubricant (Nusil MED-4162)304 Stainless SteelPlatinum
SideportPolycarbonate, High Density Polyethylene (HDPE)Polyvinyl Chloride (PVC)UV Adhesive
Hemostasis ValveAssemblyPolyisopreneBuna-N, Durometer Shore A50304 Stainless SteelAcrylonitrile butadiene styrene (ABS) with white colorantAcrylic UV CurableSilicone, Nusil Med-420Ethyl Cyanoacrylate
Lancer Dilator/Needle
ShaftPolyethylene Hexene CopolymerEthylene HomopolymerBarium Sulfate with blue colorant
Hypotube304 Stainless Steel
Needle304 Stainless Steel
Luer FittingPolycarbonate
Guidewire
GuidewirePolytetrafluoroethylene (PTFE) coated stainless steel

Table 5.4 Guider Catheter Introducer set List of Materials

{10}------------------------------------------------

There are four (4) models of the Guider Catheter Introducer set based on useable length and/or degree of tip curvature (the Lancer component is length-matched to the Guider introducer). All models have an inner diameter of 8.5 French. These include:

    1. L1 (45°), 50 cm, 8.5 French
    1. L1 (45°), 65 cm, 8.5 French
    1. L2 (90°), 50 cm, 8.5 French
    1. L2 (90°), 65 cm, 8.5 French

The Guider Catheter Introducers are shipped sterile in sealed Tyvek® pouches placed inside a cardboard shelf box and labeled single use only. Sterilization is by ethylene oxide.

5.2 Indications for Use

The Guider Catheter Introducer is indicated for introducing various cardiovascular catheters into the heart, including the left side of the heart through the interatrial septum.

5.3 Summary of Testing

The Guider Catheter Introducer set underwent the tests listed in Table 5.5. Testing was conducted at three different time intervals:

  • Baseline 2x sterilization, environmental conditioning and distribution simulation (T=0) 1)
    1. Accelerated aging - 2x sterilization and 12-month accelerated aging (T=12aa)
    1. Real-time aging - 2x sterilization and 12-month real-time aging (T=12rt).

The testing was performed by the following vendors and locations:

  • Biocompatibility testing and an animal study was performed at American Preclinical Services, ● Inc., located in Minneapolis, MN.
  • Sterilization testing was performed by Steris Isomedix, located in Minneapolis, MN.
  • Environmental Conditioning, Distribution Simulation Testing, Accelerated Aging, Peel Strength and Bubble Leak Testing were performed by Distribution Dynamic Labs, Inc. (DDL) in Eden Prairie, MN.
  • Particulate testing was performed at Nelson Labs located in Salt Lake City, UT.
  • . Electrical testing was performed at Medical Equipment Compliance Associates, LLC. (MECA) located in Franklin, WI.
  • All other testing was performed internally at CRI-Devices in Maple Grove, MN. ●

{11}------------------------------------------------

Table 5.5 SUMMARY OF TESTING
Test TypeTest Name
BiocompatibilityHemocompatibility
Cytotoxicity
Sensitization
Irritation
Pyrogenicity
Systemic Toxicity
Thrombogenicity
Sterilization ValidationLAL
Bioburden
EO residuals
PackagingEnvironmental Conditioning
Distribution Simulation -Post Environmental Conditioning
Visual Evaluation - Post Environmental Conditioning/
Distribution Simulation
Bubble Test - Post Environmental Conditioning/ Distribution
Simulation/ Visual Evaluation
Seal Strength- Post Environmental Conditioning/ Distribution
Simulation/ Visual Evaluation/ Bubble Leak
Shelf Life12 Month Accelerated Aging
12 Month Real Time Aging
InspectionCorrosion Resistance
Surface Inspection
Tip Curve Retention
Dimensional Verification
Functional TestingPushability/Trackability
Sheath Compatibility (Insertion/Withdrawal Force)
System Leak (Hemostasis, Luer, Aspiration)
Coating Integrity (Particulate, Friction)
Radiopacity
Needle Actuation
Electrical Continuity Pin-Needle
MechanicalKink Resistance
Torque Resistance
Tip/Marker band Tensile
Sheath to Hemostasis Valve Tensile
Shaft to Handle Tensile
Needle to Button Tensile
Luer to Hypo. Tensile
Flushing Tubing to Stopcock Tensile
Flushing Tubing to Hemostasis Valve Tensile
ElectricalElectrical Safety IEC 60601
Animal Study ComparingAccess from packaging
to Predicate DeviceVisual Inspection
Preparation
Preliminary Device Function
Advancement of Guidewire to Superior Vena Cava
Test TypeTest Name
Fluoroscopic Visualization
Intracardiac Echocardiographic Visualization
Fossa Ovalis Localization
Maintenance of component orientation
ECG Monitoring
Fossa Ovalis Puncture
Needle Lumen Function
Dilator Crossing of Fossa Ovalis
Sheath Crossing of Fossa Ovalis
Removal of Device
Overall Performance
Device Function -Aspirate, Flush, Transduce

{12}------------------------------------------------

5.3.1 Biocompatibility

The Guider Catheter Introducer underwent the following biocompatibility tests as shown in Table 5.6. All testing completed passed with the results listed.

Test typeTest nameResult
HemocompatibilityHemolysis Test; ASTM F756Method; Direct Contact and ExtractContactPass,Non- Hemolytic
HemocompatibilityComplement Activation; C3a Assayand SC5b-9 AssayPass,Non-Reactive
HemocompatibilityPlatelet and LeukocytePass
HemocompatibilityPartial Thromboplastin Time (PTT)Pass, Non-Activator
HemocompatibilityProthrombin Time Assay (PT)Pass
CytotoxicityMEM Elution: L-929 MouseFibroblast CellsPass,Non-Cytotoxic
SensitizationGuinea Pig Maximization (2extracts)Pass,Non-Sensitizer
IrritationIntracutaneous Reactivity Test (2extracts)Pass,Non-Irritant
PyrogenMaterials Mediated PyrogenicityTestPass,Non- Pyrogenic

{13}------------------------------------------------

Test typeTest nameResult
Systemic ToxicityAcute Systemic Toxicity Test(Aqueous and Non-AqueousExtract)Pass, Non-Toxic
In vivothrombogenicity4-hour Thrombogenicity; 2 canines,Guider and Lancer separatelyPass, Non-Thrombogenic

Results

The Guider Catheter Introducer passed all biocompatibility testing. The full protocols and results for each test are contained in this submission.

5.3.2 Sterilization

The Guider Catheter Introducer will be offered as sterile to a 10th sterility assurance level (SAL) by an ethylene oxide (EO) sterilization process. The device will undergo EO sterilization at STERIS Isomedix, located at 380 90th Ave NW, Minneapolis, MN 55433. The sterilization protocol conducted by STERIS Isomedix established the procedures for validation of an ethylene oxide sterilization process for this device. The performance qualifications will be executed using the overkill approach as referenced in the international standard, ANSI/AAMI/ISO 11135.

The following tests are conducted to assess the product sterilization:

  • · Biological Indicator Population Enumeration Testing
  • · Bioburden Testing
  • · Product Sterility Testing
  • · Bacteriostasis/Fungistasis Testing
  • · Biological Indicator Sterility Testing
  • · EO Residuals Testing

Results

The Sterilization Validation for the Guider Catheter Introducer is pending. The protocol is contained in the submission.

5.3.3 Packaging

The Guider Catheter Introducer sets are situated on a high-density polyethylene (HDPE) backer card and are shipped sterile in sealed Tyvek® pouches placed inside a cardboard shelf box and are labeled as single use only. The devices underwent the following distribution and packaging testing:

  • · Environmental Conditioning
  • · Distribution Simulation
  • · Dimensional/Visual Inspection
  • · Package Integrity/Bubble Test

{14}------------------------------------------------

  • Package Integrity/Peel Strength
    Prior to the testing, all samples had undergone 2x EO sterilization cycles at STERIS Isomedix. The sterilized units were packaged into shippers. The units/shippers were subjected to environmental conditioning followed by the distribution simulation per ASTM D 4169-09, Distributions Cycle 13; Assurance Level II, and thermal conditioning per ISTA 2A (2011).

Testing was performed by Distribution Dynamic Labs, Inc. (DDL, Inc.) located at 10200 Valley View Road, Eden Prairie, MN 55344.

Results

The Guider Catheter Introducer passed all distribution and packaging testing. The full protocols and results for each test are contained in the submission.

5.3.4 Shelf Life

The Guider Catheter Introducer will be labeled with a 12-month shelf life. In addition to baseline testing after 2x EO sterilization, environmental conditioning and distribution simulation (T=0), additional devices were subjected to 12-month accelerated aging (T=12aa) and 12-month real- time aging (T=12rt, ongoing at time of submission). The T=12aa test devices were subjected to accelerated aging environmental conditions of 55°C ± 2°C and <20% RH for 38 days to simulate the equivalent of 12 months of real-time aging as guided by ASTM F 1980-07 (2011). The Guider Catheter Introducer passed all baseline and accelerated aging testing while maintaining its sterile barrier.

5.3.5 Performance Testing

Mechanical and functional testing of the Guider Catheter Introducer with associated Lancer Integrated Dilator/Transseptal Needle, and associated kit accessories including the guidewire and ECG extension lead wire, were tested post-sterilization: immediately after manufacturing (t=0), after twelve months accelerated aging (t=12aa). Test samples have been manufactured and reserved for testing after twelve months of real-time aging has occurred (t=12rt).

{15}------------------------------------------------

Tests include:

  • Product Inspection/Dimensional Verification ●
  • Surface Inspection ●
  • Label Legibility
  • Label Adhesion ●
  • Pouch visual inspection
  • Sheath Compatibility (Insertion/Withdrawal)
  • Pushability/Trackability
  • Tip Curve Retention
  • . System Leak -Liquid Leak and Hemostasis
  • . System Leak - Luer
  • System Leak – Aspiration
  • Coating Integrity / Particulate Evaluation
  • Coating Integrity / Friction Reduction
  • Kink Resistance
  • Torque Resistance
  • Tip / Markerband Tensile
  • Sheath to Hemostasis Valve Tensile
  • Shaft to Handle Tensile
  • Needle to Button Tensile
  • Luer to Hypotube Tensile
  • Needle Actuation
  • Flush Tubing to Stopcock Tensile
  • . Flush Tubing to Hemostasis Valve Tensile
  • Electrical Safety
  • Electrical Continuity Pin-Needle
  • Corrosion Resistance
  • Package Integrity Bubble Leak ●
  • Package Integrity Peel Strength ●
  • Radiopacity

Results

All protocol requirements/specifications were met. The full protocols and results for each test are contained in the submission.

5.3.6 Animal Study

As part of Design Validation, animal testing was performed at American Preclinical Services, Inc. (APS), located in Minneapolis, MN. APS is USDA registered to conduct research in animals and is AAALAC accredited. All testing followed the requirements for Good Laboratory Practices per 21 CFR 58 as well as ISO 10993 for Biologic Evaluation of Medical Devices.

A single animal study was performed that combined the evaluation of another device cleared under K170373. This was decided due to ethical concerns to limit the number of animals required. This study compared the Guider Catheter Introducer device to the predicate device listed in Table 5.3.

{16}------------------------------------------------

Results

This study indicates that the Guider Catheter Introducer performed for the selected parameters substantially equivalent to the commercially available St. Jude Medical Swartz™ Braided Transseptal Guiding Introducer (K052644). The full report and results are included in the submission.

5.4 Comparison to the Predicate Device

The Guider Catheter Introducer and St. Jude Medical Swartz Braided Transseptal Guiding Introducer are made with similar medical-grade polymers and internal componentry. Both have varying tip geometries. The handles of each also contain a hemostasis valve and sideport tube with stopcock. Each set also includes a vessel dilator and guidewire to facilitate introduction into the vasculature and advancement to the heart.

In order to gain transseptal access to the left side of the heart, the Swartz Braided Transseptal Guiding Introducer requires the use of a separate transseptal needle.

The primary difference with the Guider is that the needle is integrated into the vessel dilator. This allows alignment of components when assembled, a length-matched needle, automatic needle tip retraction within dilator, and the ability to obtain an electrogram from the needle via an ECG adapter. Each of these functions are performed manually with the Swartz Braided Transseptal Guiding Introducer device.

These differences do not impact the intended use.

{17}------------------------------------------------

5.5 Summary of Standards Utilized in Testing

The standards used in the testing of the device are outlined in Table 5.7.

Standards No.Standards OrganizationStandards TitleVersion
110993-1ISOBiological Evaluation of Medical Devices2009
211135-1ISOSterilization of health care products - Ethylene oxide - Requirements for development, validation, and routine control of a sterilization process for medical devices2014
310555-1ISOSterile, Single-Use Intravascular Catheters2013
4F2096-11ASTMStandard Test Method for Detecting Gross Leaks in Porous Medical Packaging by Internal Pressurization (Bubble Leak)2014
5D4169-14ASTMPerformance Testing of Shipping Containers and Systems Distribution Simulation Testing2014
6F756-13ASTMStandard Practice for Assessment of Hemolytic Properties of Materials2013
760601-1:2005/(R)2012 and A1:2012AAMI/ANSI ESMedical electrical equipment - Part 1: General requirements for basic safety and essential performance2012
811607-1ISOPackaging for Terminally Sterilized Medical Devices - Part 1: Requirements for Materials, Sterile Barrier Systems and Packaging Systems2006
911607-2ISOPackaging for Terminally Sterilized Medical Devices - Part 2: Validation Requirements for Forming, Sealing and Assembly Processes2006
1014971ISOMedical Device: Application of Risk Management2012
11594-1ISOConical fittings with 6% (Luer) taper- Part 1: General requirements1986
12594-2ISOConical fittings with 6% (Luer) taper- Part 2: Lock Fittings1998
13F88/F88M-15ASTMStandard Test Method for Seal Strength of Flexible Barrier Materials2009
14F2888-13ASTMStandard Test Method for Platelet Leukocyte Count2013
1511135-1:2007ISOSterilization of Healthcare products - Ethylene oxide - Part 1: Requirements for Development, Validation, and Routine Control of a Sterilization Process for Medical Devices2007
Standards No.Standards OrganizationStandards TitleVersion
1614:2009AAMI TIRContract Sterilization Using Ethylene Oxide2009
1716:2009(R)2013AAMI TIRMicrobiological Aspects of Ethylene OxideSterilization2013
1811135-2:2008ISOSterilization of Healthcare Products - EthyleneOxide - Part 2: Guidance on the Applicationof ISO 11135-12008
1910993-7:2008(R)2012ISOBiological Evaluation of Medical Devices -Part 7: Ethylene Oxide Sterilization Residuals2012
2010993-04:2002(R)2013ISOBiological Evaluation of Medical Devices -Part 4: Selection of Tests for Interaction withBlood2013
2110993-05:2009(R)2014ISOBiological Evaluation of Medical Devices -Part 5 Tests for In Vitro Cytotoxicity2014
2210993-11:2006(R)2010ISOBiological Evaluation of Medical Devices -Part 11: Tests for Systemic Toxicity2010
2310993-12ISOBiological Evaluation of Medical Devices -Part 12: Sample Preparation and ReferenceMaterials2012
2410993-10ISOBiological Evaluation of Medical Devices -Part 10: Tests for Irritation and SkinSensitization2012
2513485:2016ISOMedical Devices --Quality ManagementSystem -- Requirements for RegulatoryPurposes2016
26F2382-04ASTMStandard Test Method for Assessment ofIntravascular Medical Device Materials onPartial Thromboplastin Time (PTT)2010
2711070:2014ISOSterile Single-use Intravascular Introducers,Dilators and Guidewires2014
28F1980-07ASTMStandard Guide for Accelerated Aging ofSterile Barrier Systems for Medical Devices2011
29F640-12ASTMStandard Test Methods for DeterminingRadiopacity for Medical Use2012
30P2AISTAPackaged Products 150lbs or less2011
3160601-1-2IECMedical electrical equipment - Part 1-2:General Requirements for Basic Safety andEssential Performance - Collateral Standard:Electromagnetic Compatibility - Requirementsand Tests2014
32ST72:2011ANSI/AAMIBacterial endotoxins - Test methods, routinemonitoring, and alternatives to batch testing2011
Standards No.StandardsOrganizationStandards TitleVersion
33Chapter 151USPPyrogen Testing2015
34Chapter 161USPTransfusion and Infusion Assemblies andSimilar Medical Devices2016
35F1886ASTMStandard Test Method for DeterminingIntegrity of Seals for Medical Packaging byVisual Inspection2016
3615223-1ISOMedical devices -- Symbols to be used withmedical device labels, labelling andinformation to be supplied -- Part 1: Generalrequirements2016

Table 5.7 Standards Utilized

{18}------------------------------------------------

{19}------------------------------------------------

5.6 Conclusions

The Guider Catheter Introducer has similar design, materials, and technical requirements as the predicate device. The Guider Catheter Introducer performs as intended, and presents no unacceptable risks to the intended patient population or end user.

The conclusion drawn from the nonclinical tests, summarized in this submission, demonstrate that the device is as safe, as effective, and performs as well as or better than the legally marketed predicate device listed in Table 5.3.

The Guider Catheter Introducer is substantially equivalent to the predicate device, the SJM Swartz Braided Transseptal Guiding Introducer (K052644).

§ 870.1340 Catheter introducer.

(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).